Hedwig Kasparu
Overview
Explore the profile of Hedwig Kasparu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clausen J, Bohm A, Strassl I, Stiefel O, Buxhofer-Ausch V, Machherndl-Spandl S, et al.
Biomedicines
. 2017 May;
5(2).
PMID: 28536356
Rabbit anti-thymocyte globulins (ATGs) are widely used for the prevention of acute and chronic graft versus host disease (aGVHD, cGVHD) following allogeneic hematopoietic stem cell transplantation (HSCT). However, most prospective...
2.
Springer A, Hammer J, Winkler E, Track C, Huppert R, Bohm A, et al.
Radiat Oncol
. 2016 Mar;
11:46.
PMID: 27000180
Background: To implement total body irradiation (TBI) using volumetric modulated arc therapy (VMAT). We applied the Varian RapidArc™ software to calculate and optimize the dose distribution. Emphasis was placed on...
3.
Ludwig H, Rauch E, Kuehr T, Adam Z, Weissmann A, Kasparu H, et al.
Haematologica
. 2014 Nov;
100(3):385-91.
PMID: 25398836
We prospectively evaluated the activity and tolerance of lenalidomide-dexamethasone in 35 patients with acute light chain-induced renal failure. The lenalidomide dose was adapted to the estimated glomerular filtration rate and...
4.
Ludwig H, Kasparu H, Leitgeb C, Rauch E, Linkesch W, Zojer N, et al.
Blood
. 2013 Nov;
123(7):985-91.
PMID: 24227817
Bendamustine with bortezomib and dexamethasone was evaluated in 79 patients with relapsed/refractory multiple myeloma. Median age was 64 years, and patients had a median of 2 prior treatment lines (range,...
5.
Worel N, Rosskopf K, Neumeister P, Kasparu H, Nachbaur D, Russ G, et al.
Transfusion
. 2010 Oct;
51(5):968-75.
PMID: 20880037
Background: Plerixafor in combination with granulocyte-colony-stimulating factor (G-CSF) has been shown to enhance stem cell mobilization in patients with multiple myeloma, non-Hodgkin's lymphoma, and Hodgkin's disease who demonstrated with previous...
6.
Danzer M, Polin H, Proll J, Haunschmid R, Hofer K, Stabentheiner S, et al.
Transplantation
. 2009 Aug;
88(4):528-32.
PMID: 19696636
Background: Hematopoietic stem-cell transplantation is a well-established treatment in various hematologic malignancies, but the outcome depends on disease relapse, infections, and the development and severity of acute and chronic graft-versus-host...
7.
Hauser H, Zach O, Krieger O, Kasparu H, Koenig J, Girschikofsky M, et al.
Blood
. 2008 Jun;
112(5):2156-9.
PMID: 18544679
A single nucleotide polymorphism (SNP) responsible for lactase persistence (LCT -13910C>T) changes intestinal microflora. Considering the influence of bacterial microflora on various immune effects, we tested DNA from 111 recipients/donors...
8.
Nachbaur D, Greinix H, Koller E, Krieger O, Linkesch W, Kasparu H, et al.
Ann Hematol
. 2005 Feb;
84(7):462-73.
PMID: 15726362
Between 1990 and 2001, 68 patients with advanced Hodgkin's disease (HD) and 86 patients classified as low-/intermediate-grade B non-Hodgkin's lymphoma (NHL) were reported to the Austrian Stem Cell Transplantation Registry...